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We did this by measuring the average length of 
stay (ALOS) of asthma inpatients for the six months 
before and the six months after the implementation 
of the pathway.  We selected patients based on 
their discharge diagnosis and time of discharge.  In 
order to avoid any confounding of the data based on 
seasonal variation, we compared the volume of asthma 
patients in each of these time periods.  We divided 
these patients into those admitted for observation and 
those admitted for a full inpatient admission.  We also 
examined the frequency of respiratory therapy consults 
on asthma patients during the period in question.  
Clinical Pathways are an increasingly common feature 
of modern healthcare.  Introducing standardization 
of thought between healthcare providers and non-
provider members of the healthcare team allows for 
greater consistency of care and – ideally – improved 
patient outcomes and satisfaction.  This fall the 
inpatient pediatric department at Lehigh Valley Health 
Network is implementing a clinical pathway around 
treatment of asthma inpatients.   The objective of 
the pathway is to eliminate inconsistency between 
providers and encourage evidence based practice, 
while simultaneously increasing patient understanding 
and reinforcing staff teamwork competencies.  It does 
this in a number of ways.  First, it utilizes an algorithm 
for scoring patients and determining the frequency of 
therapy with beta-agonists and corticosteroids.  The 
pathway also standardizes treatment with multi-dose 
inhalers (MDI) rather than nebulizer therapy (when 
possible).  Finally, the pathway involves respiratory 
therapy with every patient admitted for asthma.  This 
project sought to assess the success of the pathway in 
improving outcomes and reducing waste in the care of 
pediatric asthma patients.  
© 2016 Lehigh Valley Health Network
Methodology
The patient volumes for the pre and post-pathway periods were comparable at 
108 and 93 patients respectively.  We found that the ALOS in the full admission 
group fell by 0.48 days (p=0.0002) from 3.8 to 3.2, and rose in the observation 
group by 0.09 days (p=0.062) from 1.16 to 1.25.  When pooled, the overall 
ALOS fell by 0.67 days (p=0.0003) from 2.92 to 2.25 (Fig 1).  This shows a 
statistically significant decrease in the ALOS during inpatient admissions and 
overall admissions when pooled with observations.  The difference in ALOS of 
observations is not statistically significant.  In the pre-pathway period 38.9% of 
asthma patients received respiratory consults (Table 1).
Results
 The pathway that led to these results was not just a simple algorithm, but was rather a comprehensive suite of adjustments to the status quo of asthma 
care, including changes to the type of therapy, the frequency, the involvement 
of respiratory therapists, and the criteria for discharge.  It is important to note 
that the pathway was not a static document during the experimental period, 
but rather was subject to continuous improvement beginning immediately after 
implementation.  Continuing to improve patient care based on interdisciplinary 
feedback and objective results is essential to the successful implementation 
of clinical pathways.  This experiment shows that this clinical pathway is 
improving the care of patients while simultaneously reducing healthcare 
costs on our inpatient unit.  The improvements can be attributed to increasing 
uniformity of care, transitioning to MDI therapy, and increasing involvement 
of respiratory therapy.  One significant limitation to this experiment is the fact 
that data on readmissions during the pathway period were not available, which 
could change the conclusions drawn from these data. 
Conclusions and Future Implications
Figure 1: ALOS of Pediatric Inpatients 2015
Figure 2: Pediatrics Asthma Pathway - Inpatient
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Table 1: Pediatric Asthma Volume and           
Respiratory Consults
Jan-Dec 2015
Month/CY Inpt Obv Total Respiratory Consults
January 14 2 16 6
February 16 5 21 5
March 8 9 17 4
April 11 5 16 4
May 13 9 22 8
June 10 6 16 10
July 3 2 5 5
August 4 5 9
September 9 14 23
October 8 12 20
November 14 9 23
December 7 6 13
